We are live on ! Find out more
AA

AlphaCentric Advisors Portfolio holdings

AUM $100M
This Fund
S&P 500
This Quarter Est. Return
-5.2%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$176M
AUM Growth
-$3.89M
Cap. Flow
+$11.2M
Cap. Flow %
6.35%
Top 10 Hldgs %
22.1%
Holding
256
New
24
Increased
39
Reduced
133
Closed
21

Top Buys

Rank Stock Value
1
WBA
Walgreens Boots Alliance
WBA
+$3.86M
2
RVNC
Revance Therapeutics, Inc.
RVNC
+$3.65M
3
TSVT
2seventy bio
TSVT
+$3.13M
4
QURE icon
uniQure
QURE
+$3.1M
5
EMBC icon
Embecta
EMBC
+$2.13M

Top Sells

Rank Stock Value
1
AHCO icon
AdaptHealth
AHCO
+$3.44M
2
ELAN icon
Elanco Animal Health
ELAN
+$2.97M
3
CNC icon
Centene
CNC
+$2.7M
4
MBB icon
iShares MBS ETF
MBB
+$2.05M
5
LNTH icon
Lantheus
LNTH
+$1.93M

Sector Composition

Rank Sector Weight
1 Healthcare 61.71%
2 Real Estate 10.29%
3 Financials 3.55%
4 Technology 3.29%
5 Energy 2.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ENPH icon
226
Enphase Energy
ENPH
$5.48B
$16.5K 0.01%
137
-23
-14% -$3.28K
PHIN icon
227
Phinia Inc
PHIN
$2.97B
$12K 0.01%
+448
New +$12.4K
AHCO icon
228
AdaptHealth
AHCO
$1.49B
– –
-282,500
Closed -$3.44M
AMRN
229
Amarin Corp
AMRN
$292M
– –
-29,250
Closed -$696K
CNC icon
230
Centene
CNC
$32.8B
– –
-40,000
Closed -$2.7M
DHI icon
231
D.R. Horton
DHI
$42.4B
– –
-3,000
Closed -$365K
ECH icon
232
iShares MSCI Chile ETF
ECH
$1.01B
– –
-4,932
Closed -$144K
EIDO icon
233
iShares MSCI Indonesia ETF
EIDO
$473M
– –
-5,961
Closed -$137K
ELAN icon
234
Elanco Animal Health
ELAN
$12.9B
– –
-295,000
Closed -$2.97M
EWA icon
235
iShares MSCI Australia ETF
EWA
$1.43B
– –
-23,064
Closed -$520K
EWD icon
236
iShares MSCI Sweden ETF
EWD
$289M
– –
-3,608
Closed -$128K
EWN icon
237
iShares MSCI Netherlands ETF
EWN
$512M
– –
-2,959
Closed -$128K
FLGT icon
238
Fulgent Genetics
FLGT
$573M
– –
-39,000
Closed -$1.44M
IEI icon
239
iShares 3-7 Year Treasury Bond ETF
IEI
$18.2B
– –
-6,920
Closed -$798K
ITOS
240
DELISTED
iTeos Therapeutics
ITOS
– –
-63,000
Closed -$834K
LNTH icon
241
Lantheus
LNTH
$7B
– –
-23,000
Closed -$1.93M
LQD icon
242
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$35.2B
– –
-779
Closed -$84.2K
MBB icon
243
iShares MBS ETF
MBB
$39.3B
– –
-21,955
Closed -$2.05M
NLY icon
244
Annaly Capital Management
NLY
$16.9B
– –
-37,500
Closed -$750K
RBOT
245
DELISTED
Vicarious Surgical
RBOT
– –
-5,833
Closed -$320K
WELL icon
246
Welltower
WELL
$172B
– –
-11,059
Closed -$895K
WIP icon
247
State Street SPDR FTSE International Government Inflation-Protected Bond ETF
WIP
$492M
– –
-1,848
Closed -$77.2K
EQRX
248
DELISTED
EQRx, Inc. Common Stock
EQRX
– –
-80,000
Closed -$149K
6 7 8 9
10

Similar funds

WCM
Weber Capital Management San Francisco, California $100M AUM
FCM
Fourier Capital Management Hong Kong $100M AUM
BIA
Baer Investment Advisory Corte Madera, California $100M AUM 23.87% 1-Year Est. Return
AGAM
Audent Global Asset Management West Hollywood, California $100M AUM 22.83% 1-Year Est. Return
E
Entelevest Coral Gables, Florida $100M AUM
HCM
Hicks Capital Management Columbus, Ohio $100M AUM 14.29% 1-Year Est. Return
AC
Arrow Capital Sydney, Australia $100M AUM 68.52% 1-Year Est. Return
OIS
OneAscent Investment Solutions Birmingham, Alabama $100M AUM 15.97% 1-Year Est. Return

AlphaCentric Advisors's Q3 2023 Portfolio in Review

As of Q3 2023, AlphaCentric Advisors held 256 positions worth $176M, down 2.2% from $180M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

AlphaCentric Advisors deployed $11.2M of net new capital in Q3 2023, opening 24 new positions and adding to 39 existing holdings. Its largest new stake was Revance Therapeutics, Inc.: 190,000 shares worth $2.18M.

By sector, the portfolio is most concentrated in Healthcare at 62% of assets, up from 60% a quarter earlier, followed by Real Estate and Financials.

On the sell side, the largest reduction was Jazz Pharmaceuticals, an estimated $1.9M trimmed.

  • AlphaCentric Advisors's largest Q3 2023 buy was Revance Therapeutics, Inc.: 190,000 shares worth $2.18M.
  • AlphaCentric Advisors added most to Walgreens Boots Alliance in Q3 2023, an estimated $3.86M increase.
  • AlphaCentric Advisors's biggest Q3 2023 reduction was Jazz Pharmaceuticals, cutting an estimated $1.9M.
  • AlphaCentric Advisors fully exited AdaptHealth in Q3 2023, selling an estimated $3.44M.
  • AlphaCentric Advisors's ten largest holdings make up 22% of its $176M portfolio in Q3 2023.
  • AlphaCentric Advisors opened 24 new positions and closed 21 in Q3 2023.
  • AlphaCentric Advisors's portfolio value fell 2.2% quarter-over-quarter to $176M.

Based on AlphaCentric Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.